Fluvoxamine Maleate
Overview
Fluvoxamine Maleate is a selective serotonin reuptake inhibitor (SSRI) used primarily to treat obsessive-compulsive disorder (OCD). It is also prescribed for managing major depressive disorders and anxiety disorders.
API suppliers (7)
Suppliers of Fluvoxamine Maleate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 4 of 7 suppliers.
2 of 7 hold a GMP certificate on record in the EU or UK registers
- AMI LIFESCIENCES PRIVATE LTDIndia1 active DMF GMP on record
- Jewim Pharmaceutical (shandong) Co., Ltd.China1 active DMF
- SHANDONG RISEN-SUN PHARMACEUTICAL CO LTD1 active DMF
- MEDICHEM SASpain1 active DMF GMP on record
- TAPI NL BVNetherlands1 active DMF
- DIOSYNTH BV
- VIS FARMACEUTICI INSTITUTO SCIENTIFICO VINEZIE SPA
EU CEP holders (2)
Companies holding a valid EU Certificate of Suitability (CEP) for Fluvoxamine Maleate, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.
Therapeutic areas
Do you supply Fluvoxamine Maleate? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.